What is Antithrombin III deficiency

Antithrombin III deficiency is a rare, inherited blood disorder that significantly increases the risk of developing abnormal blood clots, known as thrombosis, particularly in the deep veins of the legs or lungs. Because antithrombin III is a critical protein that helps control blood clotting, individuals with this condition have an overactive clotting system, requiring careful medical management to prevent life-threatening complications.

What is Antithrombin III deficiency?

Antithrombin III deficiency is a thrombophilia, meaning it is a condition that predisposes the blood to clot more easily than it should. In a healthy body, the protein antithrombin III acts as a "natural anticoagulant," patrolling the bloodstream to neutralize clotting factors and keep the blood in a liquid state. When a person has Antithrombin III deficiency, their body produces either too little of this protein or a version of the protein that does not function correctly. This imbalance leaves the body vulnerable to venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE).

How common is Antithrombin III deficiency and who is affected?

Antithrombin III deficiency is a rare condition with an estimated prevalence in the general population ranging from 1 in 500 to 1 in 5,000. It affects both men and women equally, and because it is a genetic disorder, it is usually present from birth. Symptoms often do not appear until late adolescence or early adulthood, typically triggered by external factors such as surgery, pregnancy, trauma, or prolonged immobilization. Unlike some other clotting disorders, Antithrombin III deficiency is considered one of the most potent genetic risk factors for thrombosis.

What are the primary clinical classifications?

Clinicians generally categorize Antithrombin III deficiency into two main types based on how the protein behaves in the body:

• Type I (Quantitative deficiency): The most common form, where the body produces a normal-functioning protein, but the total amount of antithrombin III in the blood is significantly reduced.


• Type II (Qualitative deficiency): The body produces a normal amount of the protein, but the protein structure is defective, meaning it cannot bind to or inhibit clotting factors effectively.

Is Antithrombin III deficiency hereditary?

Yes, Antithrombin III deficiency is almost always an inherited condition, passed down through families in an autosomal dominant pattern. This means that a person only needs to inherit the altered gene from one parent to be at risk for the condition. At DiseaseMaps.org, we have seen 42 members join our community who are navigating the complexities of this diagnosis. It is important for family members of those diagnosed to seek genetic counseling, as they may also carry the genetic predisposition even if they have not yet experienced a clotting event.

What differentiates this from other clotting disorders?

While many people are familiar with Factor V Leiden or Prothrombin gene mutations, Antithrombin III deficiency is distinct because it carries a much higher risk of spontaneous clotting. Furthermore, patients with this condition often show a reduced response to heparin therapy, a common blood thinner, because heparin requires antithrombin III to function. This makes the clinical management of Antithrombin III deficiency highly specialized compared to other, more common forms of thrombophilia.

Next steps

• Consult a hematologist specializing in coagulation disorders to discuss a personalized anticoagulation management plan.


• Speak with a genetic counselor to understand inheritance patterns and discuss family screening.


• Join the DiseaseMaps.org community to connect with other patients who understand the daily challenges of living with a chronic clotting disorder.


• Keep a detailed log of any unusual symptoms, such as unexplained leg swelling, redness, or chest pain, to share with your medical team.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Antithrombin III deficiency overview.


• Orphanet: Rare disease database entry for Antithrombin deficiency.


• OMIM (Online Mendelian Inheritance in Man): Clinical synopsis for Antithrombin III.


• National Blood Clot Alliance: Educational resources on inherited thrombophilias.